The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...

Years of translational research have successfully improved treatment outcomes for common dermatological conditions such as ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to ...

Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...

The AADA continues to increase awareness among employers of the impact skin conditions have on employee health, productivity, ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

Kymera has $900 million in cash and no long-term debt, funding operations into mid-2027. Click here to read an analysis of ...

The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy,” ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...